Jonathan Davies

2007 Research Trainee Award,

Epigenomic variation in normal and cancer cells|,|

Tumour suppressor genes (TSGs) are DNA blueprints for proteins that stop cells from dividing and increasing in numbers. Each TSG comes in pairs called alleles: one from the mother and one from the father. Cancer is caused by the uncontrolled division of cells; in order for cancers to grow, both tumour suppressor alleles need to be turned off. It was previously thought that the only way to turn off genes like TSGs was through permanent changes to the normal DNA sequence, called mutations. However, another way to turn off genes is to add small chemical “tags” – called methyl groups – to a gene. This causes the DNA blueprints to fold up and become unreadable. Another complexity is that some regions of DNA that are normally folded up because of methylation become de-methylated as cancer progresses. This turns on cancer-promoting genes and increases DNA instability. Therefore, it is important to determine the DNA methylation patterns of all DNA in cancer cells in order to know what and how genes are turned on and off.

Jonathan Davies previously received a Junior Graduate Studentship from MSFHR. Now funded with at Senior Graduate Studentship, he is researching techniques to identify genes and regions in normal and cancer genomes that may be turned on or off by DNA methylation. These techniques could be used to tailor treatments to individual patients, leading to improved recovery rates, and avoiding costly and ineffectual treatments.

Previously received 2005 MSFHR Trainee Award
Read Jonathan Davies’ 2005 Trainee profile

Completed award term, March 2009

Back to 2007 Research Trainee Awards

 

Research Details

Research Area
Biomedical

University/Institution
University of British Columbia

Research Location
BC Cancer Research Centre / BC Cancer Agency

Faculty/Department
Medicine / Pathology and Laboratory Medicine

Supervisor
Dr. Wan Lam, Professor, Medicine / Pathology and Laboratory Medicine